Jack Lief

2013

In 2013, Jack Lief earned a total compensation of $4M as Former President, Chief Executive Officer and Director at Arena Pharmaceuticals, a 1% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$388,781
Option Awards$706,122
Salary$725,000
Stock Awards$2,131,200
Other$16,041
Total$3,967,144

Lief received $2.1M in stock awards, accounting for 54% of the total pay in 2013.

Lief also received $388.8K in non-equity incentive plan, $706.1K in option awards, $725K in salary and $16K in other compensation.

Rankings

In 2013, Jack Lief's compensation ranked 1,778th out of 12,286 executives tracked by ExecPay. In other words, Lief earned more than 85.5% of executives.

ClassificationRankingPercentile
All
1,778
out of 12,286
86th
Division
Manufacturing
578
out of 4,612
88th
Major group
Chemicals And Allied Products
154
out of 1,466
90th
Industry group
Drugs
104
out of 1,160
91st
Industry
Pharmaceutical Preparations
90
out of 890
90th
Source: SEC filing on April 28, 2016.

Lief's colleagues

We found five more compensation records of executives who worked with Jack Lief at Arena Pharmaceuticals in 2013.

2013

Dominic Behan

Arena Pharmaceuticals

Chief Scientific Officer

2013

Steven Spector

Arena Pharmaceuticals

General Counsel

2013

William Shanahan

Arena Pharmaceuticals

Chief Medical Officer

2013

Robert Hoffman

Arena Pharmaceuticals

Chief Financial Officer

2013

Harry Hixson

Arena Pharmaceuticals

Chief Executive Officer

You may also like